Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics’ Q2 Revenues Climb 39 Percent

NEW YORK (GenomeWeb News) – Response Genetics reported today that its second quarter revenues increased 39 percent year over year as its pharmaceutical client revenue climbed 121 percent and revenues for its ResponseDX tests increased 10 percent.

For the three months ended June 30, the molecular diagnostics firm reported revenues of $5.3 million, up from $3.8 million.

“Our pharma segment continued to be strong and our Dx revenues continued to grow year over year while we concurrently increased our gross margin from 37 percent just a year ago to over 49 percent for the quarter," Thomas Bologna, Response Genetics’ chairman & CEO, said in a statement.

During the quarter, the company signed a contract with Blue Shield of California's provider network, giving members of the health plan access to the Los Angeles-based firm's test portfolio, which includes assays for colon, lung, and gastric cancer, among others.

Response Genetics’ net loss for the quarter declined to $1.3 million, or $.04 per share, from $2.7 million, or $.11 per share, for the second quarter of 2012.

Its R&D spending declined to $447,686 from $699,791, while its SG&A inched up to $3.4 million versus $3.3 million for the prior year second quarter.

The firm finished the quarter with $5.9 million in cash and cash equivalents.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.